These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21988305)

  • 21. Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.
    Morse K; Kimizuka Y; Chan MPK; Shibata M; Shimaoka Y; Takeuchi S; Forbes B; Nirschl C; Li B; Zeng Y; Bronson RT; Katagiri W; Shigeta A; Sîrbulescu RF; Chen H; Tan RYY; Tsukada K; Brauns T; Gelfand J; Sluder A; Locascio JJ; Poznansky MC; Anandasabapathy N; Kashiwagi S
    J Immunol; 2017 Aug; 199(4):1319-1332. PubMed ID: 28710250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective and Safe Stimulation of Humoral and Cell-Mediated Immunity by Intradermal Immunization with a Cyclic Dinucleotide/Nanoparticle Combination Adjuvant.
    Hernandez-Franco JF; Mosley YC; Franco J; Ragland D; Yao Y; HogenEsch H
    J Immunol; 2021 Feb; 206(4):700-711. PubMed ID: 33380496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.
    Kumar S; Tummala H
    Mol Pharm; 2013 May; 10(5):1845-53. PubMed ID: 23506468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Nguyen TT; Choi JA; Kim JS; Park H; Yang E; Lee WJ; Baek SK; Song M; Park JH
    Vaccine; 2019 Sep; 37(40):5954-5961. PubMed ID: 31466705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvantation of epidermal powder immunization.
    Chen D; Erickson CA; Endres RL; Periwal SB; Chu Q; Shu C; Maa YF; Payne LG
    Vaccine; 2001 Apr; 19(20-22):2908-17. PubMed ID: 11282202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
    Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
    Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.
    Andrianov AK; DeCollibus DP; Gillis HA; Kha HH; Marin A; Prausnitz MR; Babiuk LA; Townsend H; Mutwiri G
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):18936-41. PubMed ID: 19864632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine.
    Weldon WC; Zarnitsyn VG; Esser ES; Taherbhai MT; Koutsonanos DG; Vassilieva EV; Skountzou I; Prausnitz MR; Compans RW
    PLoS One; 2012; 7(7):e41501. PubMed ID: 22848514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal powder immunization with protein-containing vaccines.
    Weissmueller NT; Schiffter HA; Pollard AJ
    Expert Rev Vaccines; 2013 Jun; 12(6):687-702. PubMed ID: 23750797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
    Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
    Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
    Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
    Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adjuvant GLA-AF enhances human intradermal vaccine responses.
    Carter D; van Hoeven N; Baldwin S; Levin Y; Kochba E; Magill A; Charland N; Landry N; Nu K; Frevol A; Ashman J; Sagawa ZK; Beckmann AM; Reed SG
    Sci Adv; 2018 Sep; 4(9):eaas9930. PubMed ID: 30221194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laser mimicking mosquito bites for skin delivery of malaria sporozoite vaccines.
    Zhou C; Chen X; Zhang Q; Wang J; Wu MX
    J Control Release; 2015 Apr; 204():30-7. PubMed ID: 25725360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcutaneous vaccines: novel advances in technology and delivery for overcoming the barriers.
    Li N; Peng LH; Chen X; Nakagawa S; Gao JQ
    Vaccine; 2011 Aug; 29(37):6179-90. PubMed ID: 21740946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diphtheria toxoid dissolving microneedle vaccination: Adjuvant screening and effect of repeated-fractional dose administration.
    Leone M; Romeijn S; Du G; Le Dévédec SE; Vrieling H; O'Mahony C; Bouwstra JA; Kersten G
    Int J Pharm; 2020 Apr; 580():119182. PubMed ID: 32119899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice.
    Zhang WW; Matlashewski G
    Infect Immun; 2008 Aug; 76(8):3777-83. PubMed ID: 18474642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural STING Agonist as an "Ideal" Adjuvant for Cutaneous Vaccination.
    Wang J; Li P; Wu MX
    J Invest Dermatol; 2016 Nov; 136(11):2183-2191. PubMed ID: 27287182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.
    Kimizuka Y; Katagiri W; Locascio JJ; Shigeta A; Sasaki Y; Shibata M; Morse K; Sîrbulescu RF; Miyatake M; Reeves P; Suematsu M; Gelfand J; Brauns T; Poznansky MC; Tsukada K; Kashiwagi S
    J Immunol; 2018 Dec; 201(12):3587-3603. PubMed ID: 30420435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy.
    Hammond SA; Guebre-Xabier M; Yu J; Glenn GM
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):503-26. PubMed ID: 11763499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.